DOSAL TECHNICS
The computed 12-month bankruptcy probability of DOSAL TECHNICS is 1.8% (moderate). The 2025 annual accounts show equity of €230k and a net result of €42k. Equity is growing by ~18.9% per year across the filed fiscal years. Its solvency ranks better than 46% of 7448 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €230k |
| Net result | €42k |
| Staff (FTE) | 21 |
| Better than sector | 46% |
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 41.1% | 44.0% | |
| Net result | €42k | €30k | |
| Equity | €230k | €276k | |
| Gross operating margin | €831k | €275k | |
| Staff costs | €737k | €244k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | abbreviated schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €91k | €97k | €12k | €28k | €71k |
| Net profit | €42k | €54k | €1k | €17k | €54k |
| Cash flow | €61k | €66k | €9k | €22k | €55k |
| Staff costs | €737k | €724k | €408k | €275k | €194k |
| Income taxes | €22k | €23k | €2k | €5k | €16k |
| Dividends | - | - | - | - | - |
| Total assets | €558k | €350k | €305k | €221k | €293k |
| Equity | €230k | €188k | €134k | €132k | €115k |
| Debt | €328k | €163k | €171k | €89k | €178k |
| of which ≤ 1y | €328k | €163k | €171k | €89k | €178k |
| of which > 1y | - | - | - | - | - |
| Working capital | €145k | €129k | €122k | €116k | €104k |
| Employees (FTE) | 21.0 | 20.7 | 8.9 | 7.0 | 5.5 |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 1.44 | 1.79 | 1.71 | 2.31 | 1.58 |
| Quick ratio | 1.44 | 1.79 | 1.71 | 2.31 | 1.58 |
| Working capital ratio | 26.0% | 36.8% | 40.0% | 52.5% | 35.5% |
| Solvency | 41.1% | 53.5% | 43.9% | 59.8% | 39.3% |
| Debt / equity | 1.43 | 0.87 | 1.28 | 0.67 | 1.54 |
| Long-term debt ratio | - | - | - | - | - |
| Interest coverage | 10.36 | 12.61 | 9.61 | 69.41 | 1951.90 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 7.5% | 15.4% | 0.4% | 7.7% | 18.5% |
| ROE | 18.3% | 28.7% | 0.9% | 12.9% | 47.0% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Full annual accounts (22 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €558k | €350k | €305k | €221k | €293k |
| Fixed assets | 21/28 | €84k | €59k | €12k | €16k | €11k |
| Tangible fixed assets | 22/27 | €84k | €59k | €12k | €16k | €11k |
| Current assets | 29/58 | €474k | €292k | €293k | €205k | €282k |
| Amounts receivable within one year | 40/41 | €354k | €188k | €249k | €148k | €191k |
| Cash & bank | 54/58 | €85k | €102k | €39k | €52k | €86k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €558k | €350k | €305k | €221k | €293k |
| Equity | 10/15 | €230k | €188k | €134k | €132k | €115k |
| Contributions / capital | 10/11 | €5k | €5k | €5k | €5k | €5k |
| Reserves | 13 | €95k | €55k | - | - | - |
| Accumulated profits (losses) | 14 | €130k | €128k | €129k | €127k | €110k |
| Amounts payable | 17/49 | €328k | €163k | €171k | €89k | €178k |
| Amounts payable within one year | 42/48 | €328k | €163k | €171k | €89k | €178k |
| Trade debts payable within one year | 44 | €209k | €80k | €130k | €54k | €122k |
| Income statement | ||||||
| Gross operating margin | 9900 | €831k | €824k | €422k | €305k | €268k |
| Operating result | 9901 | €72k | €85k | €4k | €23k | €70k |
| Financial income | 75 | €334 | €140 | €12 | €2 | €1 |
| Financial charges | 65 | €9k | €8k | €1k | €397 | €36 |
| Result before taxes | 9903 | €64k | €77k | €3k | €22k | €70k |
| Income taxes | 67/77 | €22k | €23k | €2k | €5k | €16k |
| Net result for the period | 9904 | €42k | €54k | €1k | €17k | €54k |
| Result to be appropriated | 9905 | €42k | €54k | €1k | €17k | €54k |
-
Khalidi BadreddineDirectorState Gazette act 22015306 (03-02-2022)Current03-02-2022 → present
| NACE primary | Site preparation(43120) |
| Legal form | Private limited company(610) |
| Incorporation | 30-09-2019 |
| Status | Active |
| Postal code | 9120 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46016D1340/00E000 | Flanders | 6,459 m² | 1 · 1,384 m² | 16.6 m |
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
03-02-2022 Khalidi Badreddine appointed as director
- Khalidi Badreddine, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Khalidi Badreddine",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0735.433.907",
"name_full": "DOSAL TECHNICS"
}
}| Legal nameNL | DOSAL TECHNICS |